BioSpace News Archive

Speak up and be heard—never before have these words pertained to lab work quite the way they do now: thanks to COATINO™, the first digital laboratory assistant that Evonik is developing especially for the coatings industry.

The Micronic Tube Reader DT500 is high-speed storage tube code reading at its best.

Velabs Therapeutics GmbH announced the closing of a €3 million Series B financing round to advance its functional antibody screening programme and to strengthen its own pipeline of preclinical functional antibodies against diseases with poor treatment options.

In a paper published in the Journal of Molecular Neuroscience scientists at Boston University School of Medicine have shown that increasing the levels of the naturally occurring Klotho protein reduces the neurological deficits and prolongs life span in an experimental model of Amyotrophic Lateral Sclerosis also known as Lou Gehrig’s disease.The leading scientists on this study are also affiliated with Klogene Therapeutics, Inc.

According to the poll results, 78% of respondents agree that the high costs of a gene therapy treatment are worth it, due to the fact that these options are seen as potential cures for disease.

Researchers at Oregon State University recently improved on a technique using magnetic nanoclusters. Their research was published in May in the journal ACS Nano.

Following an operational review, ImmunoGen will prioritize continued development of mirvetuximab, as well as a select portfolio of three earlier-stage product candidates.

Biotech and pharma companies tap new members of executive leadership teams and boards.

Polyphor AG announced the appointment of Frank Weber, M.D., as Chief Medical and Development Officer, effective September 1, 2019.

Vivoryon Therapeutics AG, announced that they have entered into a research collaboration with University Medical Center Schleswig-Holstein, Campus Kiel, to discover and develop first-in-class therapeutics in cancer immunotherapy.